Kartik Doshi, A. Varghese, D. Badyal, B. Hathiram, V. Khattar
{"title":"评价奥美拉唑治疗咽喉反流性疾病:一项单中心、前瞻性和随机研究","authors":"Kartik Doshi, A. Varghese, D. Badyal, B. Hathiram, V. Khattar","doi":"10.5005/JP-JOURNALS-10003-1186","DOIUrl":null,"url":null,"abstract":"Aims: To assess efficacy and safety of omeprazole in laryngitis due to laryngopharyngeal reflux disease (LPRD). Materials and methods: It was a prospective, randomized, open label study conducted in 90 patients with laryngitis due to LPRD. Group A (n = 45) received omeprazole and advice about life style modification, group B (n = 45) received only advice about life style modification. Reflux symptom index (RSI), reflux finding score (RFS), quality of life (QoL) and voice handicap index (VHI) were evaluated at 0, 4 and 8 weeks. Results: Percentage reduction in RSI and RFS was signi ficantly higher in group A after 8 weeks (37 vs 29%, 18 vs 13% respec tively). Excess throat mucus, clearing of throat and erythema of posterior larynx improved considerably in group A compared to group B. Conclusion: Omeprazole could be a significant addition to life style modification in LPRD patients particularly for signs and symptoms, such as excess throat mucus, clearing of throat and erythema of posterior larynx.","PeriodicalId":235775,"journal":{"name":"Otorhinolaryngology Clinics An International Journal","volume":"16 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Evaluation of Omeprazole in the Treatment of Laryngopharyngeal Reflux Disease: A Single Center, Prospective and Randomized Study\",\"authors\":\"Kartik Doshi, A. Varghese, D. Badyal, B. Hathiram, V. Khattar\",\"doi\":\"10.5005/JP-JOURNALS-10003-1186\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aims: To assess efficacy and safety of omeprazole in laryngitis due to laryngopharyngeal reflux disease (LPRD). Materials and methods: It was a prospective, randomized, open label study conducted in 90 patients with laryngitis due to LPRD. Group A (n = 45) received omeprazole and advice about life style modification, group B (n = 45) received only advice about life style modification. Reflux symptom index (RSI), reflux finding score (RFS), quality of life (QoL) and voice handicap index (VHI) were evaluated at 0, 4 and 8 weeks. Results: Percentage reduction in RSI and RFS was signi ficantly higher in group A after 8 weeks (37 vs 29%, 18 vs 13% respec tively). Excess throat mucus, clearing of throat and erythema of posterior larynx improved considerably in group A compared to group B. Conclusion: Omeprazole could be a significant addition to life style modification in LPRD patients particularly for signs and symptoms, such as excess throat mucus, clearing of throat and erythema of posterior larynx.\",\"PeriodicalId\":235775,\"journal\":{\"name\":\"Otorhinolaryngology Clinics An International Journal\",\"volume\":\"16 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Otorhinolaryngology Clinics An International Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5005/JP-JOURNALS-10003-1186\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Otorhinolaryngology Clinics An International Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5005/JP-JOURNALS-10003-1186","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
摘要
目的:评价奥美拉唑治疗咽喉反流性疾病(LPRD)所致喉炎的疗效和安全性。材料和方法:这是一项前瞻性、随机、开放标签的研究，对90例LPRD所致喉炎患者进行了研究。A组(n = 45)接受奥美拉唑治疗并接受改变生活方式的建议，B组(n = 45)只接受改变生活方式的建议。分别于0、4、8周评估反流症状指数(RSI)、反流发现评分(RFS)、生活质量(QoL)和语音障碍指数(VHI)。结果:8周后，A组RSI和RFS的减少百分比显著高于对照组(分别为37% vs 29%， 18% vs 13%)。结论:奥美拉唑对LPRD患者生活方式的改善有显著的辅助作用，特别是对喉液过多、喉清、喉后红斑等体征和症状的改善。
Evaluation of Omeprazole in the Treatment of Laryngopharyngeal Reflux Disease: A Single Center, Prospective and Randomized Study
Aims: To assess efficacy and safety of omeprazole in laryngitis due to laryngopharyngeal reflux disease (LPRD). Materials and methods: It was a prospective, randomized, open label study conducted in 90 patients with laryngitis due to LPRD. Group A (n = 45) received omeprazole and advice about life style modification, group B (n = 45) received only advice about life style modification. Reflux symptom index (RSI), reflux finding score (RFS), quality of life (QoL) and voice handicap index (VHI) were evaluated at 0, 4 and 8 weeks. Results: Percentage reduction in RSI and RFS was signi ficantly higher in group A after 8 weeks (37 vs 29%, 18 vs 13% respec tively). Excess throat mucus, clearing of throat and erythema of posterior larynx improved considerably in group A compared to group B. Conclusion: Omeprazole could be a significant addition to life style modification in LPRD patients particularly for signs and symptoms, such as excess throat mucus, clearing of throat and erythema of posterior larynx.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
